Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p/HMGB3 axis.
Apoptosis
Circ_CLIP2
Glioma
HMGB3
Proliferation
Wnt/β-catenin signaling pathway
miR-195-5p
Journal
Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
28
05
2021
accepted:
23
07
2021
pubmed:
7
8
2021
medline:
8
2
2022
entrez:
6
8
2021
Statut:
ppublish
Résumé
Circular RNA (circRNA) has been demonstrated to play key roles in regulating glioma progression. Understanding the regulatory mechanism of circRNA in glioma is vital to reveal the pathogenesis of glioma and develop novel therapeutic strategies. Therefore, our study focuses on the role and underlying mechanism of Circ_CLIP2 in glioma. The expression of Circ_CLIP2, miR-195-5p and HMGB3 in glioma cells and tissues were analyzed using qRT-PCR. Cell proliferation was determined with colony formation and MTT assays. Cell cycle and apoptosis were examined by flow cytometry. Western blot was conducted for analyzing HMGB3, PCNA, Bax, Bcl-2, cleaved-caspase 3, Wnt-1 and β-catenin. Dual-luciferase reporter assay was measured to investigate the interaction among Circ_CLIP2, miR-195-5p and HMGB3. The expression of Circ_CLIP2 and HMGB3 were increased while miR-195-5p was down-regulated in glioma cells and patients. Silencing of Circ_CLIP2 inhibited cell proliferation, enhanced cell apoptosis and inhibited the Wnt/β-catenin signaling pathway. Circ_CLIP2 suppressed miR-195-5p expression by directly sponging miR-195-5p. MiR-195-5p inhibited HMGB3 expression via directly targeting HMGB3. Knockdown of miR-195-5p facilitated cell proliferation, inhibited cell apoptosis and activated Wnt/β-catenin signaling, which were reversed by silencing of HMGB3. Knockdown of Circ_CLIP2 suppresses glioma progression by targeting miR-195-5p/HMGB3 thus inhibiting Wnt/β-catenin signaling. This study may provide potential therapeutic targets against glioma.
Sections du résumé
BACKGROUND
BACKGROUND
Circular RNA (circRNA) has been demonstrated to play key roles in regulating glioma progression. Understanding the regulatory mechanism of circRNA in glioma is vital to reveal the pathogenesis of glioma and develop novel therapeutic strategies. Therefore, our study focuses on the role and underlying mechanism of Circ_CLIP2 in glioma.
METHODS
METHODS
The expression of Circ_CLIP2, miR-195-5p and HMGB3 in glioma cells and tissues were analyzed using qRT-PCR. Cell proliferation was determined with colony formation and MTT assays. Cell cycle and apoptosis were examined by flow cytometry. Western blot was conducted for analyzing HMGB3, PCNA, Bax, Bcl-2, cleaved-caspase 3, Wnt-1 and β-catenin. Dual-luciferase reporter assay was measured to investigate the interaction among Circ_CLIP2, miR-195-5p and HMGB3.
RESULTS
RESULTS
The expression of Circ_CLIP2 and HMGB3 were increased while miR-195-5p was down-regulated in glioma cells and patients. Silencing of Circ_CLIP2 inhibited cell proliferation, enhanced cell apoptosis and inhibited the Wnt/β-catenin signaling pathway. Circ_CLIP2 suppressed miR-195-5p expression by directly sponging miR-195-5p. MiR-195-5p inhibited HMGB3 expression via directly targeting HMGB3. Knockdown of miR-195-5p facilitated cell proliferation, inhibited cell apoptosis and activated Wnt/β-catenin signaling, which were reversed by silencing of HMGB3.
CONCLUSION
CONCLUSIONS
Knockdown of Circ_CLIP2 suppresses glioma progression by targeting miR-195-5p/HMGB3 thus inhibiting Wnt/β-catenin signaling. This study may provide potential therapeutic targets against glioma.
Identifiants
pubmed: 34357490
doi: 10.1007/s11060-021-03814-7
pii: 10.1007/s11060-021-03814-7
doi:
Substances chimiques
HMGB3 Protein
0
MIRN195 microRNA, human
0
MicroRNAs
0
RNA, Circular
0
beta Catenin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
131-144Subventions
Organisme : Jiangxi provincial department of education natural science foundation youth project
ID : GJJ180153
Organisme : Science and technology plan of Jiangxi provincial health commission
ID : 20201063
Organisme : National Natural Science Foundation of China
ID : 81760445
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Reni M, Mazza E, Zanon S, Gatta G, Vecht CJ (2017) Central nervous system gliomas. Crit Rev Oncol Hematol 113:213–234. https://doi.org/10.1016/j.critrevonc.2017.03.021
doi: 10.1016/j.critrevonc.2017.03.021
pubmed: 28427510
Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 16:896–913. https://doi.org/10.1093/neuonc/nou087
doi: 10.1093/neuonc/nou087
pubmed: 24842956
pmcid: 4057143
Chen R, Smith-Cohn M, Cohen AL, Colman H (2017) Glioma Subclassifications and their clinical significance. Neurotherapeutics 14:284–297. https://doi.org/10.1007/s13311-017-0519-x
doi: 10.1007/s13311-017-0519-x
pubmed: 28281173
pmcid: 5398991
Chowdhary MM, Ene CI, Silbergeld DL (2015) Treatment of gliomas: how did we get here? Surg Neurol Int 6:S85-88. https://doi.org/10.4103/2152-7806.151348
doi: 10.4103/2152-7806.151348
pubmed: 25722937
pmcid: 4338482
Li F, Liu Z, Sun H, Li C, Wang W, Ye L, Yan C, Tian J, Wang H (2020) PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo. Acta pharmaceutica Sinica B 10:289–300. https://doi.org/10.1016/j.apsb.2019.09.004
doi: 10.1016/j.apsb.2019.09.004
pubmed: 32082974
He ZQ, Duan H, Ke C, Zhang XH, Guo CC, Al-Nahari F, Zhang J, Chen ZH, Chen YS, Liu ZG, Wang J, Chen ZP, Jiang XB, Mou YG (2017) Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas. Oncotarget 8:49605–49614. https://doi.org/10.18632/oncotarget.17849
doi: 10.18632/oncotarget.17849
pubmed: 28548947
pmcid: 5564791
Steinbach JP, Weller M (2004) Apoptosis in gliomas: molecular mechanisms and therapeutic implications. J Neurooncol 70:245–254. https://doi.org/10.1007/s11060-004-2753-4
doi: 10.1007/s11060-004-2753-4
pubmed: 15674481
Sun J, Li B, Shu C, Ma Q, Wang J (2020) Functions and clinical significance of circular RNAs in glioma. Mol Cancer 19:34. https://doi.org/10.1186/s12943-019-1121-0
doi: 10.1186/s12943-019-1121-0
pubmed: 32061256
pmcid: 7023692
Rynkeviciene R, Simiene J, Strainiene E, Stankevicius V, Usinskiene J, Miseikyte Kaubriene E, Meskinyte I, Cicenas J, Suziedelis K (2018) Non-Coding RNAs in Glioma. Cancers. https://doi.org/10.3390/cancers11010017
doi: 10.3390/cancers11010017
pubmed: 30583549
pmcid: 6356972
Mizoguchi M, Guan Y, Yoshimoto K, Hata N, Amano T, Nakamizo A, Sasaki T (2012) MicroRNAs in human malignant gliomas. J Oncol. https://doi.org/10.1155/2012/732874
doi: 10.1155/2012/732874
pubmed: 22848219
pmcid: 3400374
Zhang X, Yang H, Zhao L, Li G, Duan Y (2019) Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545. Cell Death Dis 10:616. https://doi.org/10.1038/s41419-019-1863-z
doi: 10.1038/s41419-019-1863-z
pubmed: 31409777
pmcid: 6692337
Song X, Zhang N, Han P, Moon BS, Lai RK, Wang K, Lu W (2016) Circular RNA profile in gliomas revealed by identification tool UROBORUS. Nucleic Acids Res 44:e87. https://doi.org/10.1093/nar/gkw075
doi: 10.1093/nar/gkw075
pubmed: 26873924
pmcid: 4872085
Wang X, Li XD, Fu Z, Zhou Y, Huang X, Jiang X (2020) Long noncoding RNA LINC00473/miR1955p promotes glioma progression via YAP1TEAD1Hippo signaling. Int J Oncol 56:508–521. https://doi.org/10.3892/ijo.2019.4946
doi: 10.3892/ijo.2019.4946
pubmed: 31894297
Jia Y, Tian Y, An S, Yang D (2020) Effects of microRNA-195 on the prognosis of glioma patients and the proliferation and apoptosis of human glioma cells. Pathology Oncology Research: POR 26:753–763. https://doi.org/10.1007/s12253-019-00622-3
doi: 10.1007/s12253-019-00622-3
pubmed: 30806889
Wang Y, Mo Y, Gong Z, Yang X, Yang M, Zhang S, Xiong F, Xiang B, Zhou M, Liao Q, Zhang W, Li X, Li X, Li Y, Li G, Zeng Z, Xiong W (2017) Circular RNAs in human cancer. Mol Cancer 16:25. https://doi.org/10.1186/s12943-017-0598-7
doi: 10.1186/s12943-017-0598-7
pubmed: 28143578
pmcid: 5282898
Nemeth MJ, Curtis DJ, Kirby MR, Garrett-Beal LJ, Seidel NE, Cline AP, Bodine DM (2003) Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation. Blood 102:1298–1306. https://doi.org/10.1182/blood-2002-11-3541
doi: 10.1182/blood-2002-11-3541
pubmed: 12714519
Liu J, Wang L, Li X (2018) HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR-200b-3p and miR-200c-3p. Cell Biochem Funct 36:357–365. https://doi.org/10.1002/cbf.3355
doi: 10.1002/cbf.3355
pubmed: 30232806
Li Y, Ma Y, Zhang T, Feng C, Liu Y (2020) High-mobility group box 3 (HMGB3) silencing inhibits non-small cell lung cancer development through regulating Wnt/beta-catenin pathway. Biol Chem. https://doi.org/10.1515/hsz-2020-0144
doi: 10.1515/hsz-2020-0144
pubmed: 33544474
Mu F, Huang J, Xing T, Jing Y, Cui T, Guo Y, Yan X, Li H, Wang N (2019) The Wnt/beta-catenin/LEF1 pathway promotes cell proliferation at least in part through direct upregulation of miR-17-92 cluster. Front Genet 10:525. https://doi.org/10.3389/fgene.2019.00525
doi: 10.3389/fgene.2019.00525
pubmed: 31191623
pmcid: 6549003
Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480. https://doi.org/10.1016/j.cell.2006.10.018
doi: 10.1016/j.cell.2006.10.018
pubmed: 17081971
Panda AC (2018) Circular RNAs Act as miRNA sponges. Adv Exp Med Biol 1087:67–79. https://doi.org/10.1007/978-981-13-1426-1_6
doi: 10.1007/978-981-13-1426-1_6
pubmed: 30259358
Chen TY, Liu Y, Chen L, Luo J, Zhang C, Shen XF (2020) Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis. Carcinogenesis 41:743–750. https://doi.org/10.1093/carcin/bgz194
doi: 10.1093/carcin/bgz194
pubmed: 31761927
Liu J, Zhao K, Huang N, Zhang N (2019) Circular RNAs and human glioma. Cancer Biol Med 16:11–23. https://doi.org/10.20892/j.issn.2095-3941.2018.0425
doi: 10.20892/j.issn.2095-3941.2018.0425
pubmed: 31119043
pmcid: 6528446
Wang R, Zhang S, Chen X, Li N, Li J, Jia R, Pan Y, Liang H (2018) CircNT5E Acts as a sponge of miR-422a to promote glioblastoma tumorigenesis. Cancer Res 78:4812–4825. https://doi.org/10.1158/0008-5472.CAN-18-0532
doi: 10.1158/0008-5472.CAN-18-0532
pubmed: 29967262
Li M, Li J, Liu L, Li W, Yang Y, Yuan J (2013) MicroRNA in human glioma cancers (Basel) 5:1306–1331. https://doi.org/10.3390/cancers5041306
doi: 10.3390/cancers5041306
Wang BC, Ma J (2015) Role of NicroRNAs in malignant glioma. Chin Med J (Engl) 128:1238–1244. https://doi.org/10.4103/0366-6999.156141
doi: 10.4103/0366-6999.156141
Chen J, Chen T, Zhu Y, Li Y, Zhang Y, Wang Y, Li X, Xie X, Wang J, Huang M, Sun X, Ke Y (2019) circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma. J Exp Clin Cancer Res 38:398. https://doi.org/10.1186/s13046-019-1376-8
doi: 10.1186/s13046-019-1376-8
pubmed: 31511040
pmcid: 6737709
Yilaz Susluer S, Biray Avci C, Dodurga Y, Ozlem Dogan Sigva Z, Oktar N, Gunduz C (2015) Downregulation of miR-195 via cyclosporin A in human glioblastoma cells. J BUON 20:1337–1340
pubmed: 26537083
Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, HaiYong H, Yueyang B (2013) MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PloS ONE 8:e54932. https://doi.org/10.1371/journal.pone.0054932
doi: 10.1371/journal.pone.0054932
pubmed: 23383003
pmcid: 3557299
Kulcheski FR, Christoff AP, Margis R (2016) Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol 238:42–51. https://doi.org/10.1016/j.jbiotec.2016.09.011
doi: 10.1016/j.jbiotec.2016.09.011
pubmed: 27671698
Song N, Wang B, Feng G, Duan L, Yuan S, Jia W, Liu Y (2019) Knockdown of high mobility group box 3 impairs cell viability and colony formation but increases apoptosis in A549 human non-small cell lung cancer cells. Oncol Lett 17:2937–2945. https://doi.org/10.3892/ol.2019.9927
doi: 10.3892/ol.2019.9927
pubmed: 30854071
pmcid: 6365971
Gu J, Xu T, Huang QH, Zhang CM, Chen HY (2019) HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1alpha. Cancer Manag Res 11:5075–5089. https://doi.org/10.2147/CMAR.S204357
doi: 10.2147/CMAR.S204357
pubmed: 31213919
pmcid: 6549700
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D (2014) HMGB1 in health and disease. Mol Aspects Med 40:1–116. https://doi.org/10.1016/j.mam.2014.05.001
doi: 10.1016/j.mam.2014.05.001
pubmed: 25010388
Wang P, Zhang L, Yin S, Xu Y, Tai S, Zhang LI, Liang C (2021) hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/HMGA2 axis. Acta Biochim Biophys Sin 53:815–822. https://doi.org/10.1093/abbs/gmab058
doi: 10.1093/abbs/gmab058
pubmed: 33978716
Pang B, Fan H, Zhang IY, Liu B, Feng B, Meng L, Zhang R, Sadeghi S, Guo H, Pang Q (2012) HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis. J Neurooncol 106:543–549. https://doi.org/10.1007/s11060-011-0710-6
doi: 10.1007/s11060-011-0710-6
pubmed: 21984063
Zeng Y, Que T, Lin J, Zhan Z, Xu A, Wu Z, Xie C, Luo J, Ding S, Long H, Zhang X, Song Y (2021) Oncogenic ZEB2/miR-637/HMGA1 signaling axis targeting vimentin promotes the malignant phenotype of glioma. Mol Ther Nucl acids 23:769–782. https://doi.org/10.1016/j.omtn.2020.12.029
doi: 10.1016/j.omtn.2020.12.029
Wang J, Xu X, Mo S, Tian Y, Wu J, Zhang J, Zhao J (2016) Involvement of microRNA-1297, a new regulator of HMGA1, in the regulation of glioma cell growth in vivo and in vitro. Am J Transl Res 8:2149–2158
pubmed: 27347322
pmcid: 4891427
Puca F, Tosti N, Federico A, Kuzay Y, Pepe A, Morlando S, Savarese T, D’Alessio F, Colamaio M, Sarnataro D, Ziberi S, De Martino M, Fusco A, Battista S (2019) HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells. Cell Cycle 18:1446–1457. https://doi.org/10.1080/15384101.2019.1618541
doi: 10.1080/15384101.2019.1618541
pubmed: 31116627
pmcid: 6592240
Bilir B, Kucuk O, Moreno CS (2013) Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med 11:280. https://doi.org/10.1186/1479-5876-11-280
doi: 10.1186/1479-5876-11-280
pubmed: 24188694
pmcid: 4228255
Lu C, Jia S, Zhao S, Shao X (2019) MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/beta-catenin signaling pathway. Cancer Biomark 25:115–126. https://doi.org/10.3233/CBM-192399
doi: 10.3233/CBM-192399
pubmed: 31006667
Garg M, Maurya N (2019) WNT/beta-catenin signaling in urothelial carcinoma of bladder. World J Nephrol 8:83–94. https://doi.org/10.5527/wjn.v8.i5.83
doi: 10.5527/wjn.v8.i5.83
pubmed: 31624709
pmcid: 6794554